
Ketamine Assisted Psychotherapy (KAP)
Deep Personal Healing in a Supportive Environment
What is Ketamine Assisted Therapy?
Ketamine-Assisted Psychotherapy (KAP) combines two powerful approaches- the healing potential of ketamine and the supportive guidance of therapy. Together, these methods can accelerate emotional breakthroughs, often leading to lasting improvements in mood, perspective, and well-being.
While traditional talk therapy may take years to achieve certain shifts, KAP can open the door more quickly by creating space for deep insight and healing. Many clients describe feeling more connected to themselves, more open to change, and more hopeful for the future.
How does ketamine work?
Ketamine induces a state of heightened neuroplasticity- the brain’s ability to form new connections and pathways. In this receptive state, long-held patterns linked to depression, anxiety, and trauma can begin to soften. This creates a unique opportunity to rewire rigid neural pathways, explore difficult emotions, shift perspectives, and establish healthier ways of relating to yourself and the world. By reducing psychological blocks, ketamine can support lasting transformation in mental health and overall quality of life.
Who is KAP for?
KAP may be especially supportive for individuals who have experienced:
Depression that hasn’t improved with traditional therapy or medication
Anxiety and persistent worry
PTSD or unresolved trauma
Feeling “stuck” despite personal growth work
Loss of meaning or disconnection from self
(KAP is not a first-line treatment. We carefully assess each client’s needs and history to ensure safety and fit.)
Is KAP safe?
Physiological Safety: Ketamine is considered one of the safest anesthetics in medicine. Unlike many other medications, it preserves natural breathing reflexes and maintains stable heart function. This safety profile is one reason ketamine has been widely used in hospitals for decades.
Psychological Safety: In a therapeutic setting, ketamine can gently expand awareness, shift perception, and create a state of openness. Many clients describe sessions as calming, insightful, and deeply reflective. With the support of a trained therapist, this experience can make it easier to process difficult emotions and life experiences in a safe and supported way.
Our Process
We provide ketamine in lozenge (sublingual) form through our partnering prescribers. This method is safe, effective, and allows clients to engage fully in therapy during their sessions. IV treatments are available only through our trusted affiliate providers.
Intake - Your journey begins with two assessments:
A mental health intake with your KAP therapist.
A medical evaluation with our affiliated provider who will provide the ketamine prescription.
Preparation - Before your first session, we’ll help you set intentions, discuss what to expect, and develop aftercare strategies so you feel grounded and supported every step of the way.
Exploration - In your KAP sessions, ketamine allows you to enter an expanded state of awareness. Many clients describe a sense of calm, openness, and clarity that helps them engage with emotions and life experiences from a new perspective. Your therapist will be present to guide and support you throughout.
Integration - The insights gained in your sessions are brought into everyday life through integration therapy. This step helps “anchor” your experiences, strengthen new pathways, and reduce the likelihood of old symptoms returning.
Repeat - Our standard protocol includes 6–8 exploration sessions, each followed by integration support. Dosing is adjusted gradually to your needs, comfort, and history — always with the goal of creating safe, meaningful breakthroughs.
Cost Overview
Intake + Prep Sessions: $175 (often billable to insurance)
Exploration Sessions: $550
Integration Sessions: $175 (often billable to insurance)
Ongoing Care: $175 (often billable to insurance
Current Research:
Zarate et al (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Nutt, D. J., King, L.A., & Phillips, L. D. (2010), Drug harms in the UK: a multicriteria decision analysis. The Lancet, 376(9752). 1558-1565. https://doi.org/10.1016/s0140-6736(10)61462-6
Dore J. et al (2019). Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.
aan het Rot, M. et al (2010). Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression